These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19425887)

  • 1. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?
    McQuay N; Cipolla J; Franges EZ; Thompson GE
    J Neurosurg; 2009 Oct; 111(4):666-71. PubMed ID: 19425887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
    Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
    J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
    Stein DM; Dutton RP; Kramer ME; Scalea TM
    J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury.
    Stein DM; Dutton RP; Kramer ME; Handley C; Scalea TM
    J Trauma; 2008 Mar; 64(3):620-7; discussion 627-8. PubMed ID: 18332801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury.
    Yuan Q; Wu X; Du ZY; Sun YR; Yu J; Li ZQ; Wu XH; Mao Y; Zhou LF; Hu J
    J Crit Care; 2015 Feb; 30(1):116-20. PubMed ID: 25092615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
    Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
    Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
    Nishijima DK; Dager WE; Schrot RJ; Holmes JF
    Acad Emerg Med; 2010 Mar; 17(3):244-51. PubMed ID: 20370756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury.
    Joseph B; Hadjizacharia P; Aziz H; Kulvatunyou N; Tang A; Pandit V; Wynne J; O'Keeffe T; Friese RS; Rhee P
    J Trauma Acute Care Surg; 2013 Jan; 74(1):248-53. PubMed ID: 23271101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
    Zaaroor M; Soustiel JF; Brenner B; Bar-Lavie Y; Martinowitz U; Levi L
    Acta Neurochir (Wien); 2008 Jul; 150(7):663-8. PubMed ID: 18473114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant factor VIIa in US military casualties for a five-year period.
    Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
    J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy.
    Narotam PK; Morrison JF; Nathoo N
    J Neurosurg; 2009 Oct; 111(4):672-82. PubMed ID: 19463048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
    Park P; Fewel ME; Garton HJ; Thompson BG; Hoff JT
    Neurosurgery; 2003 Jul; 53(1):34-8; discussion 38-9. PubMed ID: 12823871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive craniectomy with craniotomy: what role in the management of severe traumatic brain injury?
    Paci GM; Sise MJ; Sise CB; Sack DI; Shackford SR; Kureshi SA; Osler TM; Yale RS; Riccoboni ST; Peck KA; O'Reilly EB
    J Trauma; 2009 Sep; 67(3):531-6. PubMed ID: 19741396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study.
    DeLoughery EP; Lenfesty B; DeLoughery TG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):317-20. PubMed ID: 23429251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
    Perkins JG; Schreiber MA; Wade CE; Holcomb JB
    J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome following decompressive craniectomy in children with severe traumatic brain injury: a 10-year single-center experience with long-term follow up.
    Jagannathan J; Okonkwo DO; Dumont AS; Ahmed H; Bahari A; Prevedello DM; Jane JA; Jane JA
    J Neurosurg; 2007 Apr; 106(4 Suppl):268-75. PubMed ID: 17465359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of small-dose recombinant human coagulation factor VIIa for coagulopathy in patients with isolated traumatic brain injury].
    Pei BB; Li CY; Lu X; Wu X; Gao L; Yu J; Wu XH; Jin Y; Sun YR; Du ZY; Mao Y; Hu J; Zhou LF
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1780-3. PubMed ID: 24124708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraumatic cerebral infarction: incidence, outcome, and risk factors.
    Tawil I; Stein DM; Mirvis SE; Scalea TM
    J Trauma; 2008 Apr; 64(4):849-53. PubMed ID: 18404047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
    Stein DM; Dutton RP; Hess JR; Scalea TM
    Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.